SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000902664-24-002747
Filing Date
2024-04-04
Accepted
2024-04-04 20:33:33
Documents
2

Document Format Files

Seq Description Document Type Size
1 Q32 BIO INC. p24-1368sc13d.htm SC 13D 85995
2 JOINT FILING AGREEMENT exhibit_99.htm EX-99.4 5491
  Complete submission text file 0000902664-24-002747.txt   93112
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 781-999-0232
Q32 Bio Inc. (Subject) CIK: 0001661998 (see all company filings)

IRS No.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90433 | Film No.: 24824497
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 295 MADISON AVENUE 32ND FL NEW YORK NY 10017
Business Address 295 MADISON AVENUE 32ND FL NEW YORK NY 10017 917-940-2732
ACORN BIOVENTURES, L.P. (Filed by) CIK: 0001766853 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D